Autorepression of rfx1 gene expression: functional conservation from yeast to humans in response to DNA replication arrest.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 1291218)

Published in Mol Cell Biol on December 01, 2005

Authors

Yoav Lubelsky1, Nina Reuven, Yosef Shaul

Author Affiliations

1: Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.

Articles citing this

Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response. J Biol Chem (2009) 1.31

Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development. PLoS Genet (2011) 1.14

Pre-replication complex proteins assemble at regions of low nucleosome occupancy within the Chinese hamster dihydrofolate reductase initiation zone. Nucleic Acids Res (2010) 1.13

RFX2 is a candidate downstream amplifier of A-MYB regulation in mouse spermatogenesis. BMC Dev Biol (2009) 1.05

Candida albicans RFX2 encodes a DNA binding protein involved in DNA damage responses, morphogenesis, and virulence. Eukaryot Cell (2009) 0.99

Global regulation of genome duplication in eukaryotes: an overview from the epifluorescence microscope. Chromosoma (2008) 0.94

Regulation of FGF1 gene promoter through transcription factor RFX1. J Biol Chem (2010) 0.92

Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cells. Invest New Drugs (2009) 0.91

Convergent evolution of RFX transcription factors and ciliary genes predated the origin of metazoans. BMC Evol Biol (2010) 0.90

Identification and characterization of alternative promoters, transcripts and protein isoforms of zebrafish R2 gene. PLoS One (2011) 0.82

The Role of the Transcriptional Response to DNA Replication Stress. Genes (Basel) (2017) 0.79

The RFX protein RfxA is an essential regulator of growth and morphogenesis in Penicillium marneffei. Eukaryot Cell (2010) 0.79

Transcription factor RFX1 is crucial for maintenance of genome integrity in Fusarium graminearum. Eukaryot Cell (2014) 0.79

Ciliary dyslexia candidate genes DYX1C1 and DCDC2 are regulated by Regulatory Factor X (RFX) transcription factors through X-box promoter motifs. FASEB J (2016) 0.76

Gene targets of mouse miR-709: regulation of distinct pools. Sci Rep (2016) 0.75

Articles cited by this

A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21

Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev (2001) 12.46

Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49

Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell (2002) 7.88

Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res (1999) 7.82

Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. Mol Biol Cell (2001) 6.39

The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor. Cell (1998) 5.37

Inducible DNA repair systems. Annu Rev Biochem (1985) 4.94

Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev (2000) 3.96

Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell (1988) 3.09

The RFX-type transcription factor DAF-19 regulates sensory neuron cilium formation in C. elegans. Mol Cell (2000) 2.58

Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature (2000) 2.57

Structure and function of the radical enzyme ribonucleotide reductase. Prog Biophys Mol Biol (2001) 2.44

Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways. J Cell Sci (2000) 2.37

Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J Biol Chem (2002) 2.06

MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev (1990) 1.92

The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specification. Mol Cell Biol (2004) 1.87

Isolation of crt mutants constitutive for transcription of the DNA damage inducible gene RNR3 in Saccharomyces cerevisiae. Genetics (1992) 1.84

RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res (1996) 1.71

Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol Cell Biol (2002) 1.58

Functional organization of the hepatitis B virus enhancer. Mol Cell Biol (1990) 1.42

A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol Cell Biol (1996) 1.37

Structural basis for Chk1 inhibition by UCN-01. J Biol Chem (2002) 1.34

The sak1+ gene of Schizosaccharomyces pombe encodes an RFX family DNA-binding protein that positively regulates cyclic AMP-dependent protein kinase-mediated exit from the mitotic cell cycle. Mol Cell Biol (1995) 1.27

Graded phenotypic response to partial and complete deficiency of a brain-specific transcript variant of the winged helix transcription factor RFX4. Development (2003) 1.21

The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA. Proc Natl Acad Sci U S A (2003) 1.13

Identification of new genes regulated by the Crt1 transcription factor, an effector of the DNA damage checkpoint pathway in Saccharomyces cerevisiae. J Biol Chem (2004) 1.11

Involvement of RFX1 protein in the regulation of the human proliferating cell nuclear antigen promoter. J Biol Chem (1999) 1.01

Human regulatory factor X 4 (RFX4) is a testis-specific dimeric DNA-binding protein that cooperates with other human RFX members. J Biol Chem (2001) 1.00

Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation. J Biol Chem (1995) 0.96

The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucleic Acids Res (1997) 0.96

Phage P4 origin-binding domain structure reveals a mechanism for regulation of DNA-binding activity by homo- and heterodimerization of winged helix proteins. Mol Microbiol (2002) 0.93

Restricted expression and photic induction of a novel mouse regulatory factor X4 transcript in the suprachiasmatic nucleus. J Biol Chem (2003) 0.92

The dimerization/repression domain of RFX1 is related to a conserved region of its yeast homologues Crt1 and Sak1: a new function for an ancient motif. J Mol Biol (1999) 0.91

Regulatory factor X2 (RFX2) binds to the H1t/TE1 promoter element and activates transcription of the testis-specific histone H1t gene. J Cell Biochem (2004) 0.91

Induction of the mouse ribonucleotide reductase R1 and R2 genes in response to DNA damage by UV light. J Biol Chem (1996) 0.91

RFX1, a single DNA-binding protein with a split dimerization domain, generates alternative complexes. J Biol Chem (1998) 0.91

Activation of protein kinase C induces nuclear translocation of RFX1 and down-regulates c-myc via an intron 1 X box in undifferentiated leukemia HL-60 cells. J Biol Chem (2000) 0.90

Characterization of dRFX2, a novel RFX family protein in Drosophila. Nucleic Acids Res (2004) 0.86

Cloning and characterization of dRFX, the Drosophila member of the RFX family of transcription factors. Gene (2000) 0.86

The fungal CPCR1 protein, which binds specifically to beta-lactam biosynthesis genes, is related to human regulatory factor X transcription factors. J Biol Chem (2000) 0.85

Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107. J Virol (1998) 0.84

Characterization of the promoter of the human ribonucleotide reductase R2 gene. Biochem Biophys Res Commun (2000) 0.82

Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer element. Arch Dermatol Res (2004) 0.81

Nuclear import and DNA-binding activity of RFX1. Evidence for an autoinhibitory mechanism. Eur J Biochem (2001) 0.81

DNA-damage induction of RAD54 can be regulated independently of the RAD9- and DDC1-dependent checkpoints that regulate RNR2. Curr Genet (2002) 0.80

Mutational analysis of enhancer domains responsive to trans-activation by the X gene of human hepatitis B virus. Arch Virol (1990) 0.80

Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cells. Biochem J (2000) 0.78

The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes. Oncogene (1998) 0.78

Articles by these authors

Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell (2008) 2.38

A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev (2005) 2.21

Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A (2002) 1.91

Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol (2005) 1.84

NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A (2002) 1.80

20S proteasomes and protein degradation "by default". Bioessays (2006) 1.63

Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology (2003) 1.59

20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell (2005) 1.37

The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry (2006) 1.30

Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins (2008) 1.20

Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem (2002) 1.19

The nanny model for IDPs. Nat Chem Biol (2009) 1.18

The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1. Cancer Res (2008) 1.16

PGC-1alpha controls hepatitis B virus through nutritional signals. Proc Natl Acad Sci U S A (2006) 1.16

p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle (2005) 1.14

HBXAP, a novel PHD-finger protein, possesses transcription repression activity. Genomics (2002) 1.13

Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A (2005) 1.13

P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2003) 1.06

BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J Cell Sci (2011) 1.04

A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol Cell (2012) 1.03

c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association. J Biol Chem (2003) 1.02

Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response. J Biol Chem (2009) 0.97

Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles. J Biol Chem (2006) 0.97

Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol (2004) 0.95

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Lett (2010) 0.92

The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1. Mol Cell Biol (2013) 0.92

E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J Biol Chem (2011) 0.91

A regulatory circuit controlling Itch-mediated p73 degradation by Runx. J Biol Chem (2008) 0.90

RNA interference for antiviral therapy. J Gene Med (2006) 0.90

The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med Hypotheses (2008) 0.88

Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int (2011) 0.88

p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1. Methods Enzymol (2004) 0.87

Direct interaction of NRSF with TBP: chromatin reorganization and core promoter repression for neuron-specific gene transcription. Nucleic Acids Res (2004) 0.87

Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells. Biochem Biophys Res Commun (2005) 0.86

Mechanisms of protein degradation: an odyssey with ODC. Cell Cycle (2005) 0.86

c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol Cell Biol (2010) 0.86

The earliest steps in hepatitis B virus infection. Biochim Biophys Acta (2003) 0.86

Hepatitis B virus activates deoxynucleotide synthesis in nondividing hepatocytes by targeting the R2 gene. Hepatology (2010) 0.84

Context-dependent resistance to proteolysis of intrinsically disordered proteins. Protein Sci (2011) 0.84

The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. Biochem Biophys Res Commun (2009) 0.83

A long HBV transcript encoding pX is inefficiently exported from the nucleus. Virology (2003) 0.82

Thermo-resistant intrinsically disordered proteins are efficient 20S proteasome substrates. Mol Biosyst (2011) 0.82

NADH binds and stabilizes the 26S proteasomes independent of ATP. J Biol Chem (2014) 0.79

Interaction of hepatitis B virus with cells. Rev Med Virol (2003) 0.79

p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma. Dig Dis Sci (2002) 0.79

Ubiquitin-independent degradation: lessons from the p53 model. Isr Med Assoc J (2006) 0.77

The Hippo tumor suppressor pathway: a brainstorming workshop. Sci Signal (2009) 0.77

RNA interference--small RNAs effectively fight viral hepatitis. Liver Int (2004) 0.77

The "Trojan horse" model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector. Biochem Biophys Res Commun (2009) 0.77

Determination of IUP based on susceptibility for degradation by default. Methods Mol Biol (2012) 0.76

The role of p53 in nutrients levels. Cell Cycle (2010) 0.75